Acesso livre
Acesso livre

Infectologia

Delta “plus”: cientistas dizem que é cedo demais para afirmar o risco dessa variante da Covid-19.

28 Jun, 2021 | 10:41h

Delta plus India: Scientists say too early to tell risk of Covid-19 variant – BBC

Ver também: There are at least 200 known cases of the Delta Plus coronavirus variant worldwide. Here’s what we know – CNN

Perspectiva | Uma dose de vacina é suficiente para quem já teve COVID? O que diz a ciência.

28 Jun, 2021 | 10:40h

Is one vaccine dose enough if you’ve had COVID? What the science says – Nature

Relacionado: Another study shows a single dose of an mRNA vaccine has maximal effects in those with past infection.

 

Comentário no Twitter

 

Diretriz atualizada da IDSA sobre Covid-19 | Coinfecção e gestão antimicrobiana – “coinfecções bacterianas com infecção por SARS-CoV-2 são relativamente incomuns (provavelmente ocorrem em menos de 10% dos pacientes hospitalizados com COVID-19).”

28 Jun, 2021 | 10:38h

Co-Infection and Antimicrobial Stewardship – Infectious Diseases Society of America

Relacionado: Another study shows a high frequency of antibiotic use among patients hospitalized with Covid-19 (85.2%), despite low rates of confirmed secondary bacterial infections.

Estudo descobre que 96,1% dos pacientes se recuperaram da anosmia 1 ano depois do diagnóstico de COVID-19.

28 Jun, 2021 | 10:37h

Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis – JAMA Network Open

Comentário: Did Covid-19 take your taste and smell? Here’s when they may return – CNN E Lost Sense of Smell Returns for Almost All COVID Survivors – HealthDay

Relatório de força-tarefa sobre o diagnóstico e o manejo clínico da aspergilose pulmonar associada à COVID-19.

25 Jun, 2021 | 10:46h

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis – Intensive Care Medicine

 

Comentário no Twitter

 

“Long Covid”: estudo mostra que metade dos adultos jovens com COVID-19 apresentaram sintomas 6 meses depois da doença.

25 Jun, 2021 | 10:45h

Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds – The University of Bergen

Estudo original: Long COVID in a prospective cohort of home-isolated patients – Nature Medicine

 

Comentário no Twitter

 

[Preprint] “Long Covid”: 1/3 das pessoas infectadas apresentou sintomas de longa duração.

25 Jun, 2021 | 10:44h

Covid-19: Third of people infected have long term symptoms – The BMJ

Estudo original (preprint): Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people – Imperial College London

Grupo do CDC afirma que ainda não há evidência sugerindo a necessidade de reforço da vacina contra Covid.

25 Jun, 2021 | 10:43h

No evidence yet to suggest Covid vaccine booster is needed, CDC group says – NBC News

Opinião relacionada: 7 Reasons Why We Should Not Need Boosters for COVID-19 – by Monica Ghandi, MD

Perspectiva | As vacinas chinesas contra COVID têm desempenho inferior? A escassez de estudos de vida real deixa questões sem respostas.

25 Jun, 2021 | 10:42h

Are Chinese COVID Vaccines Underperforming? A Dearth of Real-Life Studies Leaves Unanswered Questions – Health Policy Watch

Relacionados: WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic. E Brazilian town experiment shows mass vaccination can wipe out COVID-19.

Opinião | As vacinas de mRNA são extraordinárias, mas a Novavax é ainda melhor.

25 Jun, 2021 | 10:41h

The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better – The Atlantic

Relacionado: (Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease.

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.